『Genentech』のカバーアート

Genentech

The Beginnings of Biotech

プレビューの再生

Audible会員プラン 無料体験

30日間の無料体験を試す
会員は、20万以上の対象作品が聴き放題
アプリならオフライン再生可能
プロの声優や俳優の朗読も楽しめる
Audibleでしか聴けない本やポッドキャストも多数
無料体験終了後は月会費1,500円。いつでも退会できます

Genentech

著者: Sally Smith Hughes
ナレーター: Suzie Althens
30日間の無料体験を試す

無料体験終了後は月額¥1,500。いつでも退会できます。

¥2,200 で購入

¥2,200 で購入

注文を確定する
下4桁がのクレジットカードで支払う
ボタンを押すと、Audibleの利用規約およびAmazonのプライバシー規約同意したものとみなされます。支払方法および返品等についてはこちら
キャンセル

このコンテンツについて

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise.

Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company. Hughes provides intimate portraits of the people significant to Genentech's science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits.

©2011 The University of Chicago (P)2021 Tantor
バイオテクノロジー ビジネス・キャリア

Genentechに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。